These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus. Yousefzadeh G, Gozashti M, Najafipour H, Gholamhosseinian NA, Bahramnejad A, Shokouhi M. Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870 [Abstract] [Full Text] [Related]
6. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA. Shi X, Huang G, Wang Y, Liu Z, Deng C, Li X, Zheng P, Zhou Z. Diabetologia; 2019 Mar; 62(3):399-407. PubMed ID: 30594957 [Abstract] [Full Text] [Related]
7. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. Tsiavou A, Degiannis D, Hatziagelaki E, Koniavitou K, Raptis SA. J Interferon Cytokine Res; 2004 Jul; 24(7):381-7. PubMed ID: 15296648 [Abstract] [Full Text] [Related]
8. Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes. Singh K, Martinell M, Luo Z, Espes D, Stålhammar J, Sandler S, Carlsson PO. Clin Exp Immunol; 2019 Jul; 197(1):64-73. PubMed ID: 30843600 [Abstract] [Full Text] [Related]
9. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function. Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, Huang G, Zhou Z, Liu Y. Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235 [Abstract] [Full Text] [Related]
13. Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes. Jörns A, Wedekind D, Jähne J, Lenzen S. Diabetes; 2020 Apr; 69(4):624-633. PubMed ID: 31974139 [Abstract] [Full Text] [Related]
15. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC, Action LADA Study Group. Diabetologia; 2011 Jul; 54(7):1630-8. PubMed ID: 21347621 [Abstract] [Full Text] [Related]
16. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Hjort R, Alfredsson L, Andersson T, Carlsson PO, Grill V, Groop L, Martinell M, Rasouli B, Storm P, Tuomi T, Carlsson S. Diabetes Metab; 2017 Dec; 43(6):536-542. PubMed ID: 28669512 [Abstract] [Full Text] [Related]
17. Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults - is it cost-effective? Hughes LE, Ford C, Ekbote A, Gama R. Ann Clin Biochem; 2017 Sep; 54(5):623-624. PubMed ID: 28490183 [No Abstract] [Full Text] [Related]
20. Autoimmunity-Associated PTPN22 Polymorphisms in Latent Autoimmune Diabetes of the Adult Differ from Those of Type 1 Diabetes Patients. Heneberg P, Kocková L, Čecháková M, Daňková P, Černá M. Int Arch Allergy Immunol; 2018 Sep; 177(1):57-68. PubMed ID: 29895027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]